Cargando…
HER2 Targeted Molecular MR Imaging Using a De Novo Designed Protein Contrast Agent
The application of magnetic resonance imaging (MRI) to non-invasively assess disease biomarkers has been hampered by the lack of desired contrast agents with high relaxivity, targeting capability, and optimized pharmacokinetics. We have developed a novel MR imaging probe targeting to HER2, a biomark...
Autores principales: | Qiao, Jingjuan, Li, Shunyi, Wei, Lixia, Jiang, Jie, Long, Robert, Mao, Hui, Wei, Ling, Wang, Liya, Yang, Hua, Grossniklaus, Hans E., Liu, Zhi-Ren, Yang, Jenny J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063795/ https://www.ncbi.nlm.nih.gov/pubmed/21455310 http://dx.doi.org/10.1371/journal.pone.0018103 |
Ejemplares similares
-
GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI
por: Pu, Fan, et al.
Publicado: (2015) -
Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases
por: Tan, Shanshan, et al.
Publicado: (2020) -
Novel MR imaging contrast agents for cancer detection
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2009) -
Early detection and staging of chronic liver diseases with a protein MRI contrast agent
por: Salarian, Mani, et al.
Publicado: (2019) -
Early Detection and
Staging of Lung Fibrosis Enabled
by Collagen-Targeted MRI Protein Contrast Agent
por: Ibhagui, Oluwatosin Y., et al.
Publicado: (2023)